PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Benjamin C. Creelan, MD - Taking the High Road in NSCLC: Navigating Through Immunotherapy-Based Treatments to Optimize Outcomes

Stephen V. Liu, MD - Innovation Takes the Lead in SCLC: Leveraging Evolving Advances to Drive Improved Outcomes in Limited- and Extensive-Stage Disease

Nicola Gökbuget, MD - Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies

Prof. Solange Peters, MD, PhD / Prof. David Planchard, MD, PhD - The Challenges of Choice in First-Line EGFRm NSCLC: Practical Guidance on Optimising Treatment Approaches

Sia Daneshmand, MD - Elevating NMIBC Care: Putting the Latest Innovations for Intravesical Therapies Into Practice

Prof. Eric Van Cutsem, MD, PhD - Precision Tactics With HER2-Targeting ADCs in HER2-Altered Solid Tumors: Candid Conversations and Clinical Consults

Komal Jhaveri, MD, FACP - Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations: A Framework for Multifactorial Clinical Decisions

Prof. Dr. Max S. Topp, MD - Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond

Professor John G. Gribben, MD, DSc - Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care

David A. Sallman, MD - Menin Masters for AML Care: Guidance on Integrating Menin Inhibitor Regimens and Boosting Efficacy in Challenging AML Subtypes

Joyce O'Shaughnessy, MD - Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcome

Jennifer Woyach, MD - Revealing New Sequences in CLL: Collaborative Care Planning With Real-World Evidence and Modern Therapeutics

Zachariah DeFilipp, MD - Rising to the Graft-vs-Host Disease Challenge: Progress in Treatment and Post-HCT Outcomes Across Hematologic Cancers

Noel Clarke, MBBS, FRCS ChM / Joaquin Mateo, MD, PhD / Isabela Werneck da Cunha, MD, PhD, MBA - New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies

Guillermo Garcia-Manero, MD - MASTER MDS for Enhanced Patient Care: Modern Advances With Standard and Emerging Risk-Adapted Treatment

Sagar Lonial, MD, FACP - Many Roads to Myeloma Remission: Making Sequential Choices With BCMA and Non-BCMA Immunotherapies

Prof. Dr. Martin Dreyling - Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options and Modern Clinical Decision-making in Newly Diagnosed Disease

Fred Saad, CQ, MD, FRCS, FCAHS - Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment

Ibiayi Dagogo-Jack, MD, FASCO, Van Karlyle Morris, MD - Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings

Barbara Burtness, MD / Ravindra Uppaluri, MD, PhD, FACS - Definitive Innovation in Resectable Head and Neck Cancer: New Immunotherapy Approaches in LA-HNSCC